- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03246438
Choice Architecture and Colorectal Cancer Screening Outreach
Choice Architecture and Mailed Outreach for Colorectal Cancer Screening
Study Overview
Status
Conditions
Detailed Description
This pilot study is a 3-arm randomized control trial assessing the effectiveness of sequential or active choice in CRC screening outreach vs. colonoscopy outreach only. The investigators will randomize participants to one of three study arms:
Arm 1: Direct schedule colonoscopy (Control) Arm 2: Direct schedule colonoscopy followed by mailed FIT (Sequential Choice) Arm 3: Choice of direct schedule colonoscopy or mailed FIT (Active Choice).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- University of Pennsylvania Health System
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Between 50 and 74 years old
- Has a primary care provider who is a University City or Valley Forge Family Medicine provider
- Has had at least 2 office visits at either practice
- Is due for colorectal cancer screening
- Is asymptomatic for CRC
- Subject's zip code is within the Philadelphia-Wilmington-Camden Metropolitan Statistical Area
Exclusion Criteria:
- Has had prior colonoscopy within 10 years, sigmoidoscopy within 5 years, or FOBT/FIT within twelve months of chart review (we will exclude patients who self-report any of the above procedures)
- Has a history of CRC or colonic polyps
- Has a history of GI cancer
- Has a history of confirmed Inflammatory Bowel Disease (IBD)
- has a history of colitis other than Crohns disease or ulcerative colitis)
- Has a first degree relative that has been diagnosed with CRC
- Has had a colectomy
- Has been diagnosed with Familial Adenomatous Polyposis (FAP)
- Has been diagnosed with Lynch Syndrome (i.e. HNPCC)
- Has iron-deficiency anemia
- Has a history of lower GI bleeding
- Has metastatic (Stage IV) blood or solid tumor cancer
- Has end stage renal disease
- Has cirrhosis
- Has heart failure
- Has dementia
- Has any other condition that, in the opinion of the investigator, excludes the patient from participating in this study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Control
Colonoscopy only outreach and follow-up
|
Subjects will receive a mailed communication describing the importance of colorectal cancer screening with the option to schedule a colonoscopy through a VIP direct scheduling phone line.
Subjects not scheduled after 4 weeks will receive a reminder letter to schedule colonoscopy.
Other Names:
|
|
Experimental: Sequential Choice
Colonoscopy outreach + mailed FIT follow-up
|
Subjects will receive a mailed communication describing the importance of colorectal cancer screening with the option to schedule a colonoscopy through a VIP direct scheduling phone line.
Subjects not scheduled after 4 weeks will receive a reminder letter to either schedule colonoscopy or to complete the enclosed mailed FIT kit.
Other Names:
|
|
Experimental: Active Choice
Colonoscopy + mailed FIT outreach and follow-up
|
Subjects will receive a mailed communication describing the importance of colorectal cancer screening with the option to schedule a colonoscopy through a VIP direct scheduling phone line OR complete the enclosed mailed FIT kit.
Subjects who have not completed FIT or scheduled colonoscopy within 4 weeks will be receive a reminder letter to either schedule colonoscopy or complete the mailed FIT kit previously sent.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
CRC screening completion
Time Frame: 4 months
|
The percentage of participants who successfully complete FIT or colonoscopy
|
4 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Choice of screening test
Time Frame: 4 months
|
The percentage of participants who choose either screening method (FIT vs. colonoscopy)
|
4 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Chyke Doubeni, MD, University of Pennsylvania
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 827818
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.